Showing results 1 to 2 of 2
HS-438, a new inhibitor of Imatinib-resistant BCR-ABL T315I mutation in chronic myeloid leukemia Yun, Sun-Mi; Jung, Kyung Hee; Kim, Soo Jung; Fang, Zhenghuan; Son, Mi Kwon; Yan, Hong Hua; Lee, Hyunseung; et al, CANCER LETTERS, v.348, no.1-2, pp.50 - 60, 2014-06 |
Successful hyaluronic acid filler injection in a chronic myeloid leukemia patient taking imatinib mesylate Sung, Yegyu; Kim, Min Hee; Cho, Eujin, JOURNAL OF COSMETIC AND LASER THERAPY, v.21, no.4, pp.243 - 244, 2019-05 |
Discover